GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
C

CytoMed Therapeutics GDTC · USD

Health Care · US listing · 🇺🇸 United States

Compare

0.86

0.00%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Latest on CytoMed Therapeutics

Our reporting

We have not reported on CytoMed Therapeutics yet.

Next results

13 Nov 2026

Due on 13 Nov 2026. on revenue of SGD 129,717.

Past results

Reported against what analysts expected

30 Sept 202631 Mar 202630 Sept 202528 Apr 202530 Sept 202422 Apr 2024
Earnings per share-0.12-0.11-0.07-0.07-0.07-0.04
Forecast———-0.04-0.03-0.02
RevenueSGD 121,702SGD 130,527SGD 105,715SGD 100,042SGD 82,691SGD 83,064
Forecast———SGD 130,000SGD 156,045SGD 115,300

Key events

  1. 14 Apr 2023Listed

CytoMed Therapeutics in the news

Headlines from other publishers, linked to their own pages.

Sources and methodology

Data on this tab
Our reporting and our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.